Roivant Sciences Ltd. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Roivant Sciences Ltd. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2021 to Q1 2024.
  • Roivant Sciences Ltd. Deferred Tax Assets, Valuation Allowance for the quarter ending March 31, 2024 was $767M, a 13.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $767M +$92.3M +13.7% Mar 31, 2024 10-K 2024-05-30
Q1 2023 $675M +$162M +31.6% Mar 31, 2023 10-K 2024-05-30
Q1 2022 $513M +$209M +69.1% Mar 31, 2022 10-K 2023-06-28
Q1 2021 $303M Mar 31, 2021 10-K 2022-06-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.